Modulation of glomerular ECTO-ADPase expression by oestradiol. A histochemical study

Thrombosis and Haemostasis

Volumn 77, Issue 4, 1997, Pages 767-771

  Faas, M M ^a   Bakker, W W ^a   Klok, P A ^a   Baller, J F W ^a   Schuiling, G A ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APYRASE; ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL WALL; COMPUTER ANALYSIS; CONTROLLED STUDY; DRUG IMPLANT; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GLOMERULUS; HEMOSTASIS; IMAGE ANALYSIS; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

EID: 0030974576     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656048     Document Type: Article

References (29)

1. Bakker WW, Poelstra K, Hardonk MJ. Relevance of adenine nucleotidases in the glomerular filtration barrier. Nephron 1993; 64: 338-42.
2. Lieberman GE, Lewis GP, Peters TJ. A membrane-bound enzyme in rabbit aorta capable of inhibiting adenosine-diphosphate-induced platelet aggregation. The Lancet 1977; 13: 330-2.
3. Hardonk MJ, Kalicharan D, Hulstaert CF. Cytochemical demonstration of ADP-ase activity in the rat kidney basement membrane using the cerium-based method. Acta Histochem 1985; 31: 253-61.
4. Bakker WW, Willink EJ, Donga J, Hulstaert CE, Hardonk MJ. Antithrombotic activity of glomerular adenosine diphosphatase in the glomerular basement membrane of the rat kidney. J Lab Clin Med 1987; 109: 171-7.
5. Marcus AJ, Safier LB. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J 1993; 7: 516-22.
6. Haslam RJ. Role of adenosine diphosphate in the aggregation of human blood-platelets by thrombin and by fatty acids. Nature 1964; 202: 765-8.
7. Poelstra K, Baller JFW, Hardonk MJ, Bakker WW. Demonstration of anti-thrombotic activity of glomerular adenosine diphosphatase. Blood 1991; 78: 141-8.
8. Poelstra K, Hardonk MJ, Koudstaal J, Bakker WW. Intraglomerular platelet aggregation and experimental glomerulonephritis. Oxygen free radical production inhibits ADP-ase mediated anti-thrombotic action. Kidney Int 1990; 37: 1500-8.
9. Cheung PK, Visser J, Bakker WW. Upregulation of antithrombotic ectonucleotidases by aspirin in human endothelial cells in-vitro. J Pharm Pharmacol 1994; 46: 1032-4.
10. Visscher CA, Faas MM, Bakker WW, Schuiling GA. Reproductive condition, glomerular adenosine diphosphatase activity, and platelet aggregation in the rat: effect of endotoxin. Biol Reprod 1993; 49: 1303-9.
11. Poeistra K, Baller JWF, Hardonk MJ, Bakker WW. Intraglomerular thrombotic tendency and glomerular ADPase. Unilateral impairment of ADPase elicits a proaggregatory microenvironment in experimental glomerulonephritis. Lab Invest 1991; 64: 520-5.
12. Fink G. Gonadotropin secretion and its control. In: The Physiology of Reproduction. In: Knobil E, Neill J et al., eds. New York: Raven Press 1988; pp 1349-77.
13. Jurjens H, Pratt JJ, Woldring MG. Radioimmunoassay of plasma oestradiol without extraction and chromatography. J Clin Endocrinol Metab 1975; 40: 19-25.
14. Baller JFW, Poelstra K, Hardonk MJ, Bakker WW. A modified cerium-based histochemical method for the detection of experimental induced ATP-ase impairment in the rat kidney. J Histochem Cytochem 1993; 41: 1105-9.
15. Goor H v, Gerrits PO, Hardonk MJ. Enzyme histochemical demonstration of alkaline phosphatase activity in plastic-embedded tissue using the gomori-based cerium-DAB technique. J Histochem Cytochem 1989; 37: 399-403.
16. Faas MM, Schuiling GA, Baller JFW, Visscher CA, Bakker WW. A new animal model for human pre-eclampsia: Ultralow dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 1994; 171: 158-64.
17. Chang WC, Nakao J, Neichi T, Orimo H, Murota SI. Effects of estradiol on the metabolism of arachidonic acid by aortas and platelets in rats. Biochimica et Biophysica Acta 1981; 664: 291-7.
18. Barradas MA, Mikhailidis DP, Dandona P. The effect of non-esterified fatty acids on vascular ADP-degrading enzyme activity. Diabetes Research and Clinical Practice 1987; 3: 9-19.
19. Marcus AJ, Safier LB, Hajjar KA, Ullman HL, Islam N, Broekman MJ, Eiroa AM. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. J Clin Invest 1991; 88: 1690-6.
20. Hutton RA, Chow FPR, Craft IL, Dandona P. Inhibitors of platelet aggregation in the feto-placental unit and myometrium with particular reference to the ADP-degrading property of the placenta. Placenta 1980; 1: 125-30.
21. Sullivan JM, Lobo RA. Consideration for contraception in women with cardiovascular disorders. Am J Obstet Gynecol 1993; 168: 2006-11.
22. Krauss RM, Burkman RT. The metabolic impact of oral contraceptives. Am J Obstet Gynecol 1992; 167: 1177-84.
23. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: athrogenesis and inflammation. Lab Invest 1988; 58: 249-61.
24. Emms H, Lewis GP. The anatomical distribution of ADPase activity in the rabbit aorta. Artery 1982; 10: 150-8.
25. Bonnar J, Sabra AM. Oral contraceptives and blood coagulation. J Reprod Med 1986; 31: 551-36.
26. Bonnar J. Coagulation effects of oral contraception. Am J Obstet Gynecol 1987; 157; 1042-8.
27. Basdevant A, Conard J, Pelissier C, Guyene TT, Lapousterle C, Mayer M, Guy-Grand B, Degrelle H. Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 meg to 20 mcg in oral contraceptives containing desogestrel. Contraception 1993; 48: 193-204.
28. Zahavi J, Dreyfuss F, Kalef M, Soferman N. Adenosine diphosphate-induced platelet aggregation in healthy women with and without a combined and a seqential contraceptive pill. Am J Obstet Gynecol 1973; 117: 107-13.
29. Ylikorkala O, Puolakka J, Viinikka L. The effect of oral contraceptives on antiaggregatory prostacyclin and proaggregatory thromboxane A2 in humans. Am J Obstet Gynecol 1982; 142: 573-6.